Isolation of the opioid peptide Leu-Val-Val-hemorphin-7 from bronchoalveolar lavage fluid of a patient with non-small cell lung cancer

Peptides

Volumn 21, Issue 1, 2000, Pages 137-142

  Duethman, David ^a   Dewan, Naresh ^a   Conlon, J Michael ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hemoglobin; Hemorphin; Non small cell lung cancer

Indexed keywords

HEMOGLOBIN; OPIATE PEPTIDE;

AMINO ACID COMPOSITION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

ADENOCARCINOMA; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; PEPTIDE FRAGMENTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034004877     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00186-2     Document Type: Article

References (26)

1. Balks H.J., Thim L., Conlon J.M. Circulation of a fragment of haemoglobin α-chain during a pentagastrin-induced flush in patients with metastatic carcinoid tumours. Clin Endocrinol. 28:1988;261-269.
2. Bunn P.A. Jr, Chan D., Dienhart D.G., Tolley R., Tagana M., Jewett P.B. Neuropeptides signal transduction in lung cancer clinical implications of bradykin sensitivity and overall heterogeneity . Cancer Res. 52:1992;24-31.
3. Brantl V., Gramsch C., Lottspeich F., Mertz R., Jaeger K.-H., Herz A. Novel opiod peptides derived from hemoglobin hemorphins . Eur J Pharmacol. 125:1986;309-310.
4. Cerpa-Poljak A., Lahnstein J., Mason K.E., Smythe G.A., Duncan M.W. Mass spectrometric identification and quantification of hemorphins extracted from human adrenal and pheochromocytoma tissue. J Neurochem. 68:1997;1712-1719.
5. Dagouassat N., Garreau I., Sannier F., Zhao Q., Piot J.M. Generation of VV-hemorphin-7 from globin by peritoneal macrophages. FEBS Lett. 382:1996;37-42.
6. Duffy M.J. Proteases as prognostic markers in cancer. Clin Cancer Res. 2:1996;613-618.
7. Erchegyi J., Kastin A.J., Zadina J.E., Qiu X.D. Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-Thr-Gln (valorphin) with some opiate activity. Int J Peptide Protein Res. 39:1992;477-484.
8. Gardiner S.M., Kemp P.A., Bennett T. Differential effects of captopril on regional haemodynamic responses to angiotensin-1 and bradykinin in conscious rats. Br J Pharmacol. 108:1993;169-175.
9. Glämsta E.-L., Marklund A., Hellman U., Wernstedt C., Terenius L., Nyberg F. Isolation and characterization of a hemoglobin-derived opiod peptide from the human pituitary gland. Regul Pept. 34:1991;169-179.
10. Glämsta E.-L., Meyerson B., Silberring J., Terenius L., Nyberg F. Isolation of a hemoglobin-derived opiod peptide from cerebrospinal fluid of patients with cerebrovascular bleedings. Biochem Biophys Res Commun. 184:1992;1060-1065.
11. Glämsta E.-L., Mørkrid L., Lantz I., Nyberg F. Concomitant increase in blood plasma levels of immunoreactive hemorphin-7 and β-endorphin following long distance running. Regul Pept. 49:1993;9-18.
12. Karelin A.A., Philippova M.M., Karelina E.V., Ivanov V.T. Isolation of endogenous hemorphin-related hemoglobin fragmets from bovine brain. Biochem Biophys Res Commun. 202:1994;410-415.
13. Lantz I., Glämsta E.-L., Talbäck L., Nyberg F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting activity. FEBS Lett. 287:1991;39-41.
14. Liebmann C., Schrader U., Brantl V. Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol. 166:1989;523-526.
15. Lormann H.P., Adam W., Heymer B., Kubane K.B. Microangiopathic hemolytic anemia in metastatic carcinoma. Ann Int Med. 79:1973;368-375.
16. Luthgens K., Ebert W., Trefz G., Gabrijelcic D., Turk V., Lah T. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients. Cancer Detect Prev. 17:1994;387-397.
17. Margolis M.L., Hyzy J.B., Schenken L.L., Schepart B.S. Serum tumor markers in non-small cell lung cancer. A comparative analysis. Cancer. 73:1994;605-609.
18. Moisan S., Harvey N., Beaudry G., et al. Structural requirements and mechanism of the pressor activity of Leu-Val-Val-hemorphin-7, a fragment of hemoglobin β-chain in rats. Peptides. 19:1998;119-131.
19. Nishimura K., Hazato T. Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem Biophys Res Commun. 194:1993;713-719.
20. Nyberg F., Sanderson K., Glämsta E.-L. The hemorphins a new class of opiod peptides derived from the blood protein hemoglobin . Biopolymers. 43:1997;147-156.
21. Parker S.L., Tong T., Boldens T., Wingo P.A. Cancer statistics, 1996. CA Cancer J Clin. 1996;5-27.
22. Piot J.-M., Zhao Q., Guillochon D., Ricart G., Thomas D. Isolation and characterization of two opiod peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun. 189:1992;101-110.
23. Reynolds H.Y. Bronchoalveolar lavage. Am Rev Respir Dis. 135:1987;250-263.
24. Strauss G.M., Kwiatkowski D.J., Harpole D.H., Lynch T.J., Skarin A.T., Sugarbaker D.J. Molecular and pathologic markers in stage I non-small cell carcinoma of the lung. J Clin Oncol. 13:1995;1265-1279.
25. Vassalli J.D., Pepper M.S. Membrane proteases in focus. Nature. 370:1994;14-15.
26. Zhao Q., Sannier F., Garreau I., Guillochon D., Piot J.M. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem Biophys Res Commun. 204:1994;216-223.